Trial Profile
A study evaluating the effects of Apolipoprotein E driven therapeutics for Alzheimer's disease
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 09 Jun 2013 New trial record